Table 2.
Pre-Assessment ABMT |
PT
|
Post-Assessment ABMT |
PT
|
|||||
---|---|---|---|---|---|---|---|---|
M | SD | M | SD | M | SD | M | SD | |
Attention Bias | 0.87 | 25.98 | 2.71 | 25.23 | −3.40 | 19.27 | 6.79 | 12.30 |
Vigilance | −3.93 | 25.68 | 2.86 | −13.57 | −3.07 | 15.35 | 2.64 | 9.51 |
Disengagement | 4.80 | 24.62 | 0.14 | 20.26 | −0.33 | 16.54 | 4.14 | −14.11 |
P1 | 0.20 | 0.64 | 0.15 | 0.92 | 0.00 | 0.77 | 0.08 | 0.99 |
N170 | 0.07 | 1.00 | −0.05 | 1.34 | 0.07 | 1.04 | −0.04 | 1.21 |
P2 | −0.14 | 1.12 | −0.17 | 1.37 | 0.23 | 0.94 | −0.25 | 1.43 |
N2 | 0.06 | 0.90 | 0.29 | 1.23 | 0.31 | 0.95 | −0.22 | 1.07 |
AUCI [home Day 4; min × (μg/dl) | −1.79 | 2.20 | −1.15 | 2.50 | ||||
Cortisol Reactivity (Lab; μg/dl) | −0.05 | 0.09 | 0.01 | 0.09 | ||||
AUCI [Lab; min × (μg/dl)] | −0.03 | 0.05 | 0.02 | 0.09 |
ABMT = Attention bias modification training; PT = placebo training. ERP amplitudes are the difference between the Threat-Neutral and Neutral-Neutral condition. AUCI = area under the curve with respect to increase.
If participants did not own a personal iOS device, one was provided.